{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:41:16Z","timestamp":1789072876384,"version":"build-2803163510"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Science and Technology Fund Project of Guizhou Provincial Health Commission","award":["Grant No. gzwkj2024-275"],"award-info":[{"award-number":["Grant No. gzwkj2024-275"]}]},{"name":"the Science and Technology Fund Project of Guizhou Provincial Health Commission","award":["Grant No. gzwjkj2020-1-204"],"award-info":[{"award-number":["Grant No. gzwjkj2020-1-204"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Gynostemma pentaphyllum<\/jats:italic>\n                      (GP) is known as the \u201celixir of life\u201d in Guizhou Province, China, as it has been widely consumed by the elderly. Numerous studies have shown that gypenosides (GPS) extracted from GP are involved in lipid metabolism. Apolipoprotein E (\n                      <jats:italic>ApoE<\/jats:italic>\n                      ) is a polymorphic protein with multiple biological functions, such as regulating lipid transport and iron metabolism. The deficiency of\n                      <jats:italic>ApoE<\/jats:italic>\n                      can lead to disorders in both lipid and iron metabolism. Therefore,\n                      <jats:italic>ApoE<\/jats:italic>\n                      knockout (\n                      <jats:italic>ApoE<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>\u2212\/\u2212<\/jats:italic>\n                      <\/jats:sup>\n                      ) mice are widely used in the research of disease models related to lipid and iron metabolism. It has been found through research that GPS ameliorates\n                      <jats:italic>ApoE<\/jats:italic>\n                      deficiency-induced dyslipidemia, while our prior research has established\n                      <jats:italic>ApoE<\/jats:italic>\n                      as indispensable for maintaining systemic iron homeostasis. According to the pharmacological effects of GPS, they can regulate lipid metabolism through pathways such as anti-inflammation and oxidative stress. These pathways also play a crucial role in the body\u2019s iron metabolism. Thus, this paper hypothesizes that GPS can reverse the abnormal iron metabolism caused by\n                      <jats:italic>ApoE<\/jats:italic>\n                      deficiency. It further explores the impact of GPS on iron metabolism and the underlying mechanism, aiming to provide a theoretical basis for the development of drugs that regulate iron homeostasis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We randomly divided C57BL\/6 mice were randomly divided into blank group (WT), apolipoprotein E knockout group (\n                      <jats:italic>ApoE<\/jats:italic>\n                      KO\/\n                      <jats:italic>ApoE<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>\u2212\/\u2212<\/jats:italic>\n                      <\/jats:sup>\n                      ) and gypenosides group (\n                      <jats:italic>ApoE<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>\u2212\/\u2212<\/jats:italic>\n                      <\/jats:sup>\n                      \u2009+\u2009GPS). The serum iron content, tissue iron content, transferrin receptor 1 (TfR1), ferroportin 1 (Fpn1), divalent metal transporter 1 (DMT1), iron regulatory proteins (IRPs), ferritin light chain (FTL), ferritin heavy chain (FTH), nuclear factor erythroid 2-related factor 2 (NRF2) and hepcidin expression in liver and spleen of the three groups of mice were studied.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The results demonstrate that gypenosides reduce\n                      <jats:italic>ApoE<\/jats:italic>\n                      deficiency-induced iron accumulation by downregulating TfR1 (a cellular iron import protein) and upregulating Fpn1 (an iron export protein). In the spleen of\n                      <jats:italic>ApoE<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>\u2212\/\u2212<\/jats:italic>\n                      <\/jats:sup>\n                      mice, this regulation occurs through Nrf2-dependent upregulation of Fpn1 and IRP2-mediated downregulation of TfR1, whereas in the liver, neither Nrf2 nor IRPs play a dominant role in the altered expression of TfR1 and Fpn1 induced by\n                      <jats:italic>ApoE<\/jats:italic>\n                      knockout.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Gypenosides can reduce tissue iron accumulation in the liver and spleen of\n                      <jats:italic>ApoE<\/jats:italic>\n                      -deficient mice, suggesting that, based on its function in regulating lipid metabolism, gypenosides also possess the potential ability to regulate iron metabolism.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40001-026-03871-6","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T11:24:42Z","timestamp":1768217082000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of saponins from gynostemma pentaphyllum on iron metabolism in apolipoprotein E deficient mice"],"prefix":"10.1186","volume":"31","author":[{"given":"Tingyun","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwen","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"issue":"20","key":"3871_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26206249","volume":"26","author":"C Su","year":"2021","unstructured":"Su C, Li N, Ren R, Wang Y, Su X, Lu F, et al. Progress in the medicinal value, bioactive compounds, and pharmacological activities of Gynostemma pentaphyllum. Molecules. 2021;26(20):6249. https:\/\/doi.org\/10.3390\/molecules26206249.","journal-title":"Molecules"},{"key":"3871_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.113574","volume":"268","author":"NH Nguyen","year":"2021","unstructured":"Nguyen NH, Ha TKQ, Yang JL, Pham HTT, Oh WK. Triterpenoids from the genus Gynostemma: chemistry and pharmacological activities. J Ethnopharmacol. 2021;268:113574. https:\/\/doi.org\/10.1016\/j.jep.2020.113574.","journal-title":"J Ethnopharmacol"},{"issue":"Pt 1","key":"3871_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117186","volume":"319","author":"P Xie","year":"2024","unstructured":"Xie P, Luo HT, Pei WJ, Xiao MY, Li FF, Gu YL, et al. Saponins derived from Gynostemma pentaphyllum regulate triglyceride and cholesterol metabolism and the mechanisms: a review. J Ethnopharmacol. 2024;319(Pt 1):117186. https:\/\/doi.org\/10.1016\/j.jep.2023.117186.","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"3871_CR4","first-page":"205","volume":"24","author":"L Zhou","year":"2008","unstructured":"Zhou L, Xu YP, Wei Y, Shi XP, Liu CP. [The effect of Gynostemma pentaphyllum (GP) on plasma lipoprotein metabolism and lipoperoxidation lipoprotein in the experimental hyperglycemia rats]. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2008;24(2):205\u20138.","journal-title":"Zhongguo Ying Yong Sheng Li Xue Za Zhi"},{"key":"3871_CR5","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.15225","volume":"11","author":"T Zhou","year":"2023","unstructured":"Zhou T, Cao L, Du Y, Qin L, Lu Y, Zhang Q, et al. Gypenosides ameliorate high-fat diet-induced nonalcoholic fatty liver disease in mice by regulating lipid metabolism. PeerJ. 2023;11:e15225. https:\/\/doi.org\/10.7717\/peerj.15225.","journal-title":"PeerJ"},{"issue":"7","key":"3871_CR6","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1177\/00220345241242389","volume":"103","author":"BY Chen","year":"2024","unstructured":"Chen BY, Pathak JL, Lin HY, Guo WQ, Chen WJ, Luo G, et al. Inflammation triggers chondrocyte ferroptosis in TMJOA via HIF-1\u03b1\/TFRC. J Dent Res. 2024;103(7):712\u201322. https:\/\/doi.org\/10.1177\/00220345241242389.","journal-title":"J Dent Res"},{"issue":"16","key":"3871_CR7","doi-asserted-by":"publisher","first-page":"4527","DOI":"10.1128\/MCB.00200-09","volume":"29","author":"EB Rankin","year":"2009","unstructured":"Rankin EB, Rha J, Selak MA, Unger TL, Keith B, Liu Q, et al. Hypoxia-inducible factor 2 regulates hepatic lipid metabolism. Mol Cell Biol. 2009;29(16):4527\u201338. https:\/\/doi.org\/10.1128\/MCB.00200-09.","journal-title":"Mol Cell Biol"},{"issue":"1\u20133","key":"3871_CR8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1089\/ars.2023.0380","volume":"41","author":"L Yang","year":"2024","unstructured":"Yang L, Liu Q, Lu Q, Xiao JJ, Fu AY, Wang S, et al. Scavenger receptor class B type I deficiency induces iron overload and ferroptosis in renal tubular epithelial cells via hypoxia-inducible factor-1\u03b1\/transferrin receptor 1 signaling pathway. Antioxid Redox Signal. 2024;41(1\u20133):56\u201373. https:\/\/doi.org\/10.1089\/ars.2023.0380.","journal-title":"Antioxid Redox Signal"},{"key":"3871_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2024.104349","volume":"197","author":"Q Pang","year":"2024","unstructured":"Pang Q, Tang Z, Luo L. The crosstalk between oncogenic signaling and ferroptosis in cancer. Crit Rev Oncol Hematol. 2024;197:104349. https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104349.","journal-title":"Crit Rev Oncol Hematol"},{"key":"3871_CR10","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1146\/annurev-physiol-020518-114742","volume":"81","author":"DM Ward","year":"2019","unstructured":"Ward DM, Cloonan SM. Mitochondrial iron in human health and disease. Annu Rev Physiol. 2019;81:453\u201382. https:\/\/doi.org\/10.1146\/annurev-physiol-020518-114742.","journal-title":"Annu Rev Physiol"},{"issue":"8","key":"3871_CR11","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/j.1440-1681.2011.05661.x","volume":"39","author":"GJ Anderson","year":"2012","unstructured":"Anderson GJ, Wang F. Essential but toxic: controlling the flux of iron in the body. Clin Exp Pharmacol Physiol. 2012;39(8):719\u201324. https:\/\/doi.org\/10.1111\/j.1440-1681.2011.05661.x.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"3","key":"3871_CR12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/s0165-0173(98)00012-5","volume":"27","author":"ZM Qian","year":"1998","unstructured":"Qian ZM, Wang Q. Expression of iron transport proteins and excessive iron accumulation in the brain in neurodegenerative disorders. Brain Res Brain Res Rev. 1998;27(3):257\u201367. https:\/\/doi.org\/10.1016\/s0165-0173(98)00012-5.","journal-title":"Brain Res Brain Res Rev"},{"issue":"3","key":"3871_CR13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.pneurobio.2007.07.009","volume":"83","author":"Y Ke","year":"2007","unstructured":"Ke Y, Qian ZM. Brain iron metabolism: neurobiology and neurochemistry. Prog Neurobiol. 2007;83(3):149\u201373. https:\/\/doi.org\/10.1016\/j.pneurobio.2007.07.009.","journal-title":"Prog Neurobiol"},{"issue":"3","key":"3871_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/s1471-4914(00)01910-9","volume":"7","author":"ZM Qian","year":"2001","unstructured":"Qian ZM, Shen X. Brain iron transport and neurodegeneration. Trends Mol Med. 2001;7(3):103\u20138. https:\/\/doi.org\/10.1016\/s1471-4914(00)01910-9.","journal-title":"Trends Mol Med"},{"issue":"4","key":"3871_CR15","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/s1474-4422(03)00353-3","volume":"2","author":"Y Ke","year":"2003","unstructured":"Ke Y, Ming Qian Z. Iron misregulation in the brain: a primary cause of neurodegenerative disorders. Lancet Neurol. 2003;2(4):246\u201353. https:\/\/doi.org\/10.1016\/s1474-4422(03)00353-3.","journal-title":"Lancet Neurol"},{"issue":"5","key":"3871_CR16","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1111\/brv.12521","volume":"94","author":"ZM Qian","year":"2019","unstructured":"Qian ZM, Ke Y. Brain iron transport. Biol Rev Camb Philos Soc. 2019;94(5):1672\u201384. https:\/\/doi.org\/10.1111\/brv.12521.","journal-title":"Biol Rev Camb Philos Soc"},{"issue":"2","key":"3871_CR17","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/med.21631","volume":"40","author":"ZM Qian","year":"2020","unstructured":"Qian ZM, Ke Y. Hepcidin and its therapeutic potential in neurodegenerative disorders. Med Res Rev. 2020;40(2):633\u201353. https:\/\/doi.org\/10.1002\/med.21631.","journal-title":"Med Res Rev"},{"key":"3871_CR18","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.csbj.2017.05.003","volume":"15","author":"IF Tudorache","year":"2017","unstructured":"Tudorache IF, Trusca VG, Gafencu AV. Apolipoprotein E - a multifunctional protein with implications in various pathologies as a result of its structural features. Comput Struct Biotechnol J. 2017;15:359\u201365. https:\/\/doi.org\/10.1016\/j.csbj.2017.05.003.","journal-title":"Comput Struct Biotechnol J"},{"issue":"5","key":"3871_CR19","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00109-004-0631-3","volume":"83","author":"K Greenow","year":"2005","unstructured":"Greenow K, Pearce NJ, Ramji DP. The key role of apolipoprotein E in atherosclerosis. J Mol Med (Berl). 2005;83(5):329\u201342. https:\/\/doi.org\/10.1007\/s00109-004-0631-3.","journal-title":"J Mol Med (Berl)"},{"issue":"8","key":"3871_CR20","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.tem.2023.05.002","volume":"34","author":"LG Yang","year":"2023","unstructured":"Yang LG, March ZM, Stephenson RA, Narayan PS. Apolipoprotein E in lipid metabolism and neurodegenerative disease. Trends Endocrinol Metab. 2023;34(8):430\u201345. https:\/\/doi.org\/10.1016\/j.tem.2023.05.002.","journal-title":"Trends Endocrinol Metab"},{"issue":"11","key":"3871_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113479","volume":"19","author":"GS Getz","year":"2018","unstructured":"Getz GS, Reardon CA. Apoprotein E and reverse cholesterol transport. Int J Mol Sci. 2018;19(11):3479. https:\/\/doi.org\/10.3390\/ijms19113479.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"3871_CR22","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41593-023-01288-6","volume":"26","author":"ZP Chen","year":"2023","unstructured":"Chen ZP, Wang S, Zhao X, Fang W, Wang Z, Ye H, et al. Lipidaccumulated reactive astrocytes promote disease progression in epilepsy. Nat Neurosci. 2023;26(4):542\u201354. https:\/\/doi.org\/10.1038\/s41593-023-01288-6.","journal-title":"Nat Neurosci"},{"issue":"4","key":"3871_CR23","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.tcb.2023.09.004","volume":"34","author":"IA Windham","year":"2024","unstructured":"Windham IA, Cohen S. The cell biology of APOE in the brain. Trends Cell Biol. 2024;34(4):338\u201348. https:\/\/doi.org\/10.1016\/j.tcb.2023.09.004.","journal-title":"Trends Cell Biol"},{"key":"3871_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2021.05.007","volume":"328","author":"YA Khalil","year":"2021","unstructured":"Khalil YA, Rab\u00e8s JP, Boileau C, Varret M. APOE gene variants in primary dyslipidemia. Atherosclerosis. 2021;328:11\u201322. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.05.007.","journal-title":"Atherosclerosis"},{"key":"3871_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.857933","volume":"9","author":"J Ma","year":"2022","unstructured":"Ma J, Ma HM, Shen MQ, Wang YY, Bao YX, Liu Y, et al. The role of iron in atherosclerosis in Apolipoprotein E deficient mice. Front Cardiovasc Med. 2022;9:857933. https:\/\/doi.org\/10.3389\/fcvm.2022.857933.","journal-title":"Front Cardiovasc Med"},{"key":"3871_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.101865","volume":"40","author":"J Ma","year":"2021","unstructured":"Ma J, Qian C, Bao Y, Liu MY, Ma HM, Shen MQ, et al. Apolipoprotein e deficiency induces a progressive increase in tissue iron contents with age in mice. Redox Biol. 2021;40:101865. https:\/\/doi.org\/10.1016\/j.redox.2021.101865.","journal-title":"Redox Biol"},{"key":"3871_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102779","volume":"64","author":"J Ma","year":"2023","unstructured":"Ma J, Guo Q, Shen MQ, Li W, Zhong QX, Qian ZM. Apolipoprotein e is required for brain iron homeostasis in mice. Redox Biol. 2023;64:102779. https:\/\/doi.org\/10.1016\/j.redox.2023.102779.","journal-title":"Redox Biol"},{"issue":"9","key":"3871_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094591","volume":"22","author":"AS Vogt","year":"2021","unstructured":"Vogt AS, Arsiwala T, Mohsen M, Vogel M, Manolova V, Bachmann MF. On iron metabolism and its regulation. Int J Mol Sci. 2021;22(9):4591. https:\/\/doi.org\/10.3390\/ijms22094591.","journal-title":"Int J Mol Sci"},{"issue":"13","key":"3871_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23137267","volume":"23","author":"RJ Ward","year":"2022","unstructured":"Ward RJ, Dexter DT, Crichton RR. Iron, neuroinflammation and neurodegeneration. Int J Mol Sci. 2022;23(13):7267. https:\/\/doi.org\/10.3390\/ijms23137267.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3871_CR30","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3945\/an.116.013961","volume":"8","author":"V Sangkhae","year":"2017","unstructured":"Sangkhae V, Nemeth E. Regulation of the iron homeostatic hormone hepcidin. Adv Nutr. 2017;8(1):126\u201336. https:\/\/doi.org\/10.3945\/an.116.013961.","journal-title":"Adv Nutr"},{"issue":"12","key":"3871_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126493","volume":"22","author":"E Nemeth","year":"2021","unstructured":"Nemeth E, Ganz T. Hepcidin-ferroportin interaction controls systemic iron homeostasis. Int J Mol Sci. 2021;22(12):6493. https:\/\/doi.org\/10.3390\/ijms22126493.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3871_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010449","volume":"24","author":"L Rochette","year":"2022","unstructured":"Rochette L, Dogon G, Rigal E, Zeller M, Cottin Y, Vergely C. Lipid peroxidation and iron metabolism: two corner stones in the homeostasis control of ferroptosis. Int J Mol Sci. 2022;24(1):449. https:\/\/doi.org\/10.3390\/ijms24010449.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"3871_CR33","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/jpp\/rgae005","volume":"76","author":"YL Yang","year":"2024","unstructured":"Yang YL, Zhao CZ, Zhao CC, Wen ZY, Ma YY, Zhao XN, et al. Ling-gui-zhu-gan decoction protects against doxorubicin-induced myocardial injury by downregulating ferroptosis. J Pharm Pharmacol. 2024;76(4):405\u201315. https:\/\/doi.org\/10.1093\/jpp\/rgae005.","journal-title":"J Pharm Pharmacol"},{"key":"3871_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101107","volume":"23","author":"M Dodson","year":"2019","unstructured":"Dodson M, Castro-Portuguez R, Zhang DD. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol. 2019;23:101107. https:\/\/doi.org\/10.1016\/j.redox.2019.101107.","journal-title":"Redox Biol"},{"issue":"7","key":"3871_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073612","volume":"23","author":"Y Tian","year":"2022","unstructured":"Tian Y, Tian Y, Yuan Z, Zeng Y, Wang S, Fan X, et al. Iron metabolism in aging and age-related diseases. Int J Mol Sci. 2022;23(7):3612. https:\/\/doi.org\/10.3390\/ijms23073612.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"3871_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2019.118535","volume":"1866","author":"D Galaris","year":"2019","unstructured":"Galaris D, Barbouti A, Pantopoulos K. Iron homeostasis and oxidative stress: an intimate relationship. Biochimica et Biophysica Acta (BBA). 2019;1866(12):118535. https:\/\/doi.org\/10.1016\/j.bbamcr.2019.118535.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"6","key":"3871_CR37","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1007\/s12035-020-02277-7","volume":"58","author":"N Zhang","year":"2021","unstructured":"Zhang N, Yu X, Xie J, Xu H. New insights into the role of ferritin in iron homeostasis and neurodegenerative diseases. Mol Neurobiol. 2021;58(6):2812\u201323. https:\/\/doi.org\/10.1007\/s12035-020-02277-7.","journal-title":"Mol Neurobiol"},{"issue":"2","key":"3871_CR38","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41580-023-00648-1","volume":"25","author":"B Galy","year":"2024","unstructured":"Galy B, Conrad M, Muckenthaler M. Mechanisms controlling cellular and systemic iron homeostasis. Nat Rev Mol Cell Biol. 2024;25(2):133\u201355. https:\/\/doi.org\/10.1038\/s41580-023-00648-1.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3871_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2019.103413","volume":"101","author":"N Ammal Kaidery","year":"2019","unstructured":"Ammal Kaidery N, Ahuja M, Thomas B. Crosstalk between Nrf2 signaling and mitochondrial function in Parkinson\u2019s disease. Mol Cell Neurosci. 2019;101:103413. https:\/\/doi.org\/10.1016\/j.mcn.2019.103413.","journal-title":"Mol Cell Neurosci"},{"key":"3871_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00176","volume":"5","author":"N Wilkinson","year":"2014","unstructured":"Wilkinson N, Pantopoulos K. The IRP\/IRE system in vivo: insights from mouse models. Front Pharmacol. 2014;5:176. https:\/\/doi.org\/10.3389\/fphar.2014.00176.","journal-title":"Front Pharmacol"},{"key":"3871_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00160","volume":"7","author":"G Sebastiani","year":"2016","unstructured":"Sebastiani G, Wilkinson N, Pantopoulos K. Pharmacological targeting of the hepcidin\/ferroportin axis. Front Pharmacol. 2016;7:160. https:\/\/doi.org\/10.3389\/fphar.2016.00160.","journal-title":"Front Pharmacol"},{"issue":"5704","key":"3871_CR42","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1126\/science.1104742","volume":"306","author":"E Nemeth","year":"2004","unstructured":"Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306(5704):2090\u20133. https:\/\/doi.org\/10.1126\/science.1104742.","journal-title":"Science"},{"issue":"2","key":"3871_CR43","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41416-022-01753-2","volume":"127","author":"JH Joachim","year":"2022","unstructured":"Joachim JH, Mehta KJ. Hepcidin in hepatocellular carcinoma. Br J Cancer. 2022;127(2):185\u201392. https:\/\/doi.org\/10.1038\/s41416-022-01753-2.","journal-title":"Br J Cancer"},{"issue":"4","key":"3871_CR44","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1053\/j.ackd.2019.04.005","volume":"26","author":"AK Agarwal","year":"2019","unstructured":"Agarwal AK, Yee J. Hepcidin. Adv Chronic Kidney Dis. 2019;26(4):298\u2013305. https:\/\/doi.org\/10.1053\/j.ackd.2019.04.005.","journal-title":"Adv Chronic Kidney Dis"},{"key":"3871_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107877","volume":"226","author":"P Sagar","year":"2021","unstructured":"Sagar P, Angmo S, Sandhir R, Rishi V, Yadav H, Singhal NK. Effect of hepcidin antagonists on anemia during inflammatory disorders. Pharmacol Ther. 2021;226:107877. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107877.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"3871_CR46","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s12035-014-8847-x","volume":"52","author":"F Du","year":"2015","unstructured":"Du F, Qian ZM, Luo Q, Yung WH, Ke Y. Hepcidin suppresses brain iron accumulation by downregulating iron transport proteins in iron-overloaded rats. Mol Neurobiol. 2015;52(1):101\u201314. https:\/\/doi.org\/10.1007\/s12035-014-8847-x.","journal-title":"Mol Neurobiol"},{"issue":"3","key":"3871_CR47","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1007\/s12011-011-8967-3","volume":"143","author":"L Li","year":"2011","unstructured":"Li L, Holscher C, Chen BB, Zhang ZF, Liu YZ. Hepcidin treatment modulates the expression of divalent metal transporter-1, ceruloplasmin, and ferroportin-1 in the rat cerebral cortex and hippocampus. Biol Trace Elem Res. 2011;143(3):1581\u201393. https:\/\/doi.org\/10.1007\/s12011-011-8967-3.","journal-title":"Biol Trace Elem Res"},{"key":"3871_CR48","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1146\/annurev-med-043021-032816","volume":"74","author":"E Nemeth","year":"2023","unstructured":"Nemeth E, Ganz T. Hepcidin and iron in health and disease. Annu Rev Med. 2023;74:261\u201377. https:\/\/doi.org\/10.1146\/annurev-med-043021-032816.","journal-title":"Annu Rev Med"},{"issue":"4","key":"3871_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/ph12040170","volume":"12","author":"ZJ Hawula","year":"2019","unstructured":"Hawula ZJ, Wallace DF, Subramaniam VN, Rishi G. Therapeutic advances in regulating the hepcidin\/ferroportin axis. Pharmaceuticals (Basel). 2019;12(4):170. https:\/\/doi.org\/10.3390\/ph12040170.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"6","key":"3871_CR50","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1172\/JCI67225","volume":"123","author":"N Zhao","year":"2013","unstructured":"Zhao N, Zhang AS, Enns CA. Iron regulation by hepcidin. J Clin Invest. 2013;123(6):2337\u201343. https:\/\/doi.org\/10.1172\/JCI67225.","journal-title":"J Clin Invest"},{"issue":"8","key":"3871_CR51","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/nm.4146","volume":"22","author":"I Theurl","year":"2016","unstructured":"Theurl I, Hilgendorf I, Nairz M, Tymoszuk P, Haschka D, Asshoff M, et al. On-demand erythrocyte disposal and iron recycling requires transient macrophages in the liver. Nat Med. 2016;22(8):945\u201351. https:\/\/doi.org\/10.1038\/nm.4146.","journal-title":"Nat Med"},{"issue":"3","key":"3871_CR52","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.cell.2016.12.034","volume":"168","author":"MU Muckenthaler","year":"2017","unstructured":"Muckenthaler MU, Rivella S, Hentze MW, Galy B. A red carpet for iron metabolism. Cell. 2017;168(3):344\u201361. https:\/\/doi.org\/10.1016\/j.cell.2016.12.034.","journal-title":"Cell"},{"issue":"17","key":"3871_CR53","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1089\/ars.2017.7176","volume":"29","author":"MJ Kerins","year":"2018","unstructured":"Kerins MJ, Ooi A. The roles of NRF2 in modulating cellular iron homeostasis. Antioxid Redox Signal. 2018;29(17):1756\u201373. https:\/\/doi.org\/10.1089\/ars.2017.7176.","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"3871_CR54","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.abb.2011.02.001","volume":"508","author":"N Harada","year":"2011","unstructured":"Harada N, Kanayama M, Maruyama A, Yoshida A, Tazumi K, Hosoya T, et al. Nrf2 regulates ferroportin 1-mediated iron efflux and counteracts lipopolysaccharide-induced ferroportin 1 mRNA suppression in macrophages. Arch Biochem Biophys. 2011;508(1):101\u20139. https:\/\/doi.org\/10.1016\/j.abb.2011.02.001.","journal-title":"Arch Biochem Biophys"},{"key":"3871_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2024.111077","volume":"397","author":"K Ping","year":"2024","unstructured":"Ping K, Yang R, Chen H, Xie S, Li M, Xiang Y, et al. Gypenoside XLIX alleviates intestinal injury by inhibiting sepsis-induced inflammation, oxidative stress, apoptosis, and autophagy. Chem Biol Interact. 2024;397:111077. https:\/\/doi.org\/10.1016\/j.cbi.2024.111077.","journal-title":"Chem Biol Interact"},{"key":"3871_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176766","volume":"978","author":"G Liang","year":"2024","unstructured":"Liang G, Lee YZ, Kow ASF, Lee QL, Cheng Lim LW, Yusof R, et al. Neuroprotective effects of Gypenosides: a review on preclinical studies in neuropsychiatric disorders. Eur J Pharmacol. 2024;978:176766. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176766.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"3871_CR57","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cell.2010.06.028","volume":"142","author":"MW Hentze","year":"2010","unstructured":"Hentze MW, Muckenthaler MU, Galy B, Camaschella C. Two to tango: regulation of mammalian iron metabolism. Cell. 2010;142(1):24\u201338. https:\/\/doi.org\/10.1016\/j.cell.2010.06.028.","journal-title":"Cell"},{"key":"3871_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00124","volume":"5","author":"DL Zhang","year":"2014","unstructured":"Zhang DL, Ghosh MC, Rouault TA. The physiological functions of iron regulatory proteins in iron homeostasis - an update. Front Pharmacol. 2014;5:124. https:\/\/doi.org\/10.3389\/fphar.2014.00124.","journal-title":"Front Pharmacol"},{"issue":"1","key":"3871_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-017-0218-4","volume":"12","author":"ZD Zhou","year":"2017","unstructured":"Zhou ZD, Tan EK. Iron regulatory protein (IRP)-iron responsive element (IRE) signaling pathway in human neurodegenerative diseases. Mol Neurodegener. 2017;12(1):75. https:\/\/doi.org\/10.1186\/s13024-017-0218-4.","journal-title":"Mol Neurodegener"},{"key":"3871_CR60","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.freeradbiomed.2018.07.020","volume":"133","author":"I Yanatori","year":"2019","unstructured":"Yanatori I, Kishi F. DMT1 and iron transport. Free Radic Biol Med. 2019;133:55\u201363. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.07.020.","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"3871_CR61","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/ki.2013.142","volume":"84","author":"B Moulouel","year":"2013","unstructured":"Moulouel B, Houamel D, Delaby C, Tchernitchko D, Vaulont S, Letteron P, et al. Hepcidin regulates intrarenal iron handling at the distal nephron. Kidney Int. 2013;84(4):756\u201366. https:\/\/doi.org\/10.1038\/ki.2013.142.","journal-title":"Kidney Int"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-026-03871-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-026-03871-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-026-03871-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T13:53:40Z","timestamp":1770645220000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-026-03871-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3871"],"URL":"https:\/\/doi.org\/10.1186\/s40001-026-03871-6","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animals care and experimental protocols were conducted in accordance with the Animal Management Rules of the Ministry of Health of China and were approved by the Animal Ethics Committees of Zunyi Medical University (ZMU21-2503\u2013415). Informed consent was not applicable in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"260"}}